The present invention relates to compounds of the formula I or II: (I) (II) processes for their preparation and their use as pharmaceutical agents or compositions in the treatment, of neurological disorders.
The present invention relates to compounds of the formula I or II: (I) (II) processes for their preparation and their use as pharmaceutical agents or compositions in the treatment, of neurological disorders.
本发明涉及式 I 或式 II 的化合物:(I) (II) 它们的制备工艺及其作为药剂或组合物治疗神经系统疾病的用途。
4H-pyrido[1,2-a]pyrimidin-4-one compounds
申请人:Prana Biotechnology Limited
公开号:US11008319B2
公开(公告)日:2021-05-18
The present invention relates to compounds of the formula I or II: (I) (II) processes for their preparation and their use as pharmaceutical agents or compositions in the treatment, of neurological disorders.
本发明涉及式 I 或式 II 的化合物:(I) (II) 它们的制备工艺及其作为药剂或组合物治疗神经系统疾病的用途。
4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS
申请人:Prana Biotechnology Ltd
公开号:EP3227292A1
公开(公告)日:2017-10-11
4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS
申请人:Prana Biotechnology Limited
公开号:US20170267676A1
公开(公告)日:2017-09-21
The present invention relates to compounds of the formula I or II: (I) (II) processes for their preparation and their use as pharmaceutical agents or compositions in the treatment, of neurological disorders.